User Ratings

Your rating: None
Your rating: None
Your rating: None
Add your comments

Preparation of Soluble Proteins from Escherichia coli

Paul T. Wingfield1

1National Institutes of Health, Bethesda, Maryland

Unit Number: 
Unit 6.2
DOI: 
10.1002/0471140864.ps0602s41
Online Posting Date: 
September, 2005
GO TO THE FULL TEXT:
PDF or HTML at Wiley Online Library
Are you the author of this protocol? Login or register and return to this page.
Learn more about the author(s): 
Paul Wingfield

Abstract

Purification of human IL-1 is used in this unit as an example of the preparation of soluble proteins from E. coli. Bacteria containing IL-1 are lysed, and IL-1 in the resulting supernatant is purified by anion-exchange chromatography, salt precipitation and cation-exchange chromatography, and then concentrated. Finally, the IL-1 protein is applied to a gel-filtration column to separate it from remaining higher- and lower-molecular-weight contaminants, the purified protein is stored frozen or is lyophilized. The purification protocol described is typical for a protein that is expressed in fairly high abundance (i.e., >5% total protein) and accumulates in a soluble state.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Unit Introduction
  • Basic Protocol: Purification of a Protein Expressed in Escherichia coli in a Soluble State: Interleukin 1
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol: Purification of a Protein Expressed in Escherichia coli in a Soluble State: Interleukin 1

 Materials
  • DEAE Sepharose CL-4B resin (Amersham Biosciences)
  • Anion-exchange buffer (see recipe)
  • 0.26% (w/v) sodium hypochlorite/70% ethanol or 5% (v/v) bleach (e.g., Clorox)/70% ethanol
  • E. coli cells (~50 g wet weight) from fermentation (unit 5.3) containing IL-1
  • Lysis buffer (see recipe)
  • Bovine pancreas DNase I and RNase A (Worthington Biochemical; optional, for reducing solution viscosity)
  • 2 N sodium hydroxide
  • Ammonium sulfate, ground with mortar and pestle
  • Cation-exchange buffer (see recipe)
  • CM Sepharose CL-4B (Amersham Biosciences)
  • Cation-exchange buffer/250 mM NaCl (see recipe)
  • Tris base
  • Gel-filtration buffer (see recipe)
  • Ultrogel AcA54 gel-permeation resin (BioSepra; Ciphergen)
  • Lyophilization buffer (see recipe; optional)
  • 2- or 3-liter sintered glass funnel with fritted disc (coarse porosity) and 5-liter filter flask
  • Chromatography columns (preferably glass) with adjustable flow adapters: one (or optionally two) 5 × 50 cm and one 2.5 × 100 cm (Amersham Biosciences, Amicon, or equivalent)
  • RK50 packing reservoir (Amersham Biosciences)
  • Peristaltic pump, UV monitor, and fraction collector (Amersham Biosciences or equivalent)
  • 16 × 150–mm culture tubes
  • 40-ml French pressure cell and rapid-fill kit (Thermo Electron Corp.)
  • French laboratory press (Thermo Electron Corp.)
  • 1-liter Waring commercial blender.
  • 250, 500, and 1000-ml stainless steel beakers
  • Ice bucket, ~4 liter
  • Tissue-grinder homogenizer (Polytron Model PT 10/35, Brinkmann)
  • Ultrasonic homogenizer, ³400 W, with sound enclosure (Branson or equivalent)
  • Preparative centrifuge: Beckman J2-21M or Avanti J series
  • Rotors for preparative centrifuge: Beckman JA-14 (capacity 6 × 250 ml) or JA-20 (capacity 8 × 50 ml)
  • Ultracentrifuge: Beckman Optima XL-90 or Optima L-90 k
  • Rotors for ultracentrifuge: Beckman 45Ti (capacity 6 × 100 ml) or 35Ti (capacity 6 × 94 ml)
  • Conductivity meter (Radiometer Analytical)
  • Spectra/Por 1 dialysis tubing (Spectrum Labs)
  • Gradient maker: Model GM-2000 (1000 ml per side with side outlet; CBS Scientific); smaller-capacity gradient makers are also available (Amersham Biosciences)
  • 200- or 400-ml stirred ultrafiltration cell and PM10 or YM3 Ultracel Amicon ultrafiltation discs (Millipore)
  • Millex-GV 0.22-µm-pore-size filter units (Millipore)
  • 10- or 20-ml syringe
  • Additional materials and equipment for SDS-PAGE (unit 10.1) and dialysis (appendix 3B)

NOTE: All protocol steps are carried at 4°C unless otherwise stated. Forces for centrifugation steps refer to the maximum × g (i.e., centrifugal force at the bottom of the tubes).

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  • Figure 6.2.1
    Cell component distribution and typical expression levels obtained in E. coli. The asterisks (*) refer to purification yields of proteins expressed in E. coli in the soluble or insoluble states.

  • Figure 6.2.2
    Scheme for purifying human interleukin-1.

  • Figure 6.2.3
    Purification of IL-1. (A) SDS-PAGE analysis of samples at various stages. Analysis was conducted on a gel of dimensions 12 cm × 16 cm × 1.5 mm. Lane a, purified protein (100 µg loaded); lane b, purified protein (10 µg loaded); lane d, CM Sepharose pool (80%); lane e, DEAE Sepharose pool after ammonium sulfate fractionation (56%); lane f, high-speed supernatant (starting material for DEAE Sepharose column; 13.5%); lane g, cell lysate (12.0%). The percentages refer to specific IL-1 contents of the fractions determined by densitomeric scanning of the Coomassie blue–stained gel lanes. Lanes c and h contain the following protein standards (low-range standards supplied by Bio-Rad) in order of increasing migration distance: phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), hen egg white ovalbumin (45 kDa), bovine carbonic anhydrase (31 kDa), soybean trypsin inhibitor (21.5 kDa), and hen white lysozyme (14.4 kDa). (B) Analysis of results from gel filtration on Ultrogel AcA54. The excluded volume (V0) and the fully included volume (Vi) are indicated. Inset, analytical rechromatography of the protein from the pooled fractions (indicated P in larger chromatogram).

  • Figure 6.2.4
    Common methods used to purify soluble recombinant proteins. Abbreviations: IMAC, immobilized metal affinity chromatography; HIC, hydrophobic interaction chromatography.

  • Figure 6.2.5
    Checklist of issues to consider when planning a purification strategy.

  • Figure 6.2.6
    Initial protein purification methods typically involve centrifugation (the specific conditions vary according to culture scale and location of expressed protein), (NH4)2SO4 precipitation, or polyethylene glycol (PEG) precipitation.

  • Figure 6.2.7
    Purification of the HIV-1 protein Nef and the anti-HIV protein MAP30.

  • Figure 6.2.8
    Purification of the DNA-binding protein Ner of bacteriophage Mu. This basic (pI ~ 10) 9-kDa protein regulates phage lysogenic and lytic activity.

  • Figure 6.2.9
    Issues to consider for ion exchange chromatography.

  • Figure 6.2.10
    Chromatofocusing of IL-1. (A) Theoretical titration curve of IL-1 with N-terminal methionine (M+) and N-terminal alanine (M). (B) Chromatofocusing of a mixture of IL-1 M+ and IL-1 M. Chromatography was performed using a Mono HR5/20 column (Amersham Bioscience) as described by Wingfield et al. (1987).

Literature Cited

Literature Cited
    Allet, B., Payton, M., Mattalino, R.J., Turcatti, G., Gronenborn, A.M., Clore, G.M., and Wingfield, P.T. 1988. The purification and characterization of the bacteriophage Mu DNA-binding protein Ner. Gene 65:259-268.
    Bass, S. and Yang, M. 1997. Expressing cloned genes in Escherichia coli. In Protein Function: A Practical Approach, 2nd ed. (T.E.Creighton, ed) pp. 29-55. IRL Press, Oxford.
    Burgess, R.R. and Jendrisak, J.J. 1975. A procedure for the rapid, large-scale purification of E. coli DNA-dependent RNA polymerase involving polymin P precipitation and DNA-cellulose chromatography. J. Biol. Chem. 14:4634-4638.
    Choi, J.H. and Lee, S.Y. 2004. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl. Microbiol. Biotechnol. 64:625-635.
    Chrunyk, B.A., Evans, J., Lillquist, J., Young, P., and Wetzel, R. 1993. Inclusion body formation and protein stability in sequence variants of Interleukin-1. J. Biol. Chem. 268:18053-18061.
    Clore, G.M., Wingfield, P.T., and Gronenborn, A.M. 1991. High-resolution structure of interleukin 1 in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. Biochemistry 30:2315-2323.
    Dinarello, C.A. 1989. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:153-205.
    Gery, I. and Schmidt, J.A. 1985. Human interleukin 1. Methods Enzymol. 116:456-467.
    Hlodan, R. and Hartl, F.U. 1994. How the protein folds in the cell. In Mechanisms of Protein Folding (R.H. Pain, ed.) pp. 194-228. IRL Press, Oxford.
    Hopkins, T.R. 1991. Physical and chemical cell disruption for the recovery of intracellular proteins. In Purification and Analysis of Recombinant Proteins (R. Seetharam and S.K. Sharma, eds.) pp. 57-83. Marcel Dekker, New York.
    Ito, T. and Wagner, G. 2004. Using codon optimization, chaperone co-expression, and rational mutagensis for production and NMR assignments of human eIF2a. J. Biomol. NMR. 28:257-267.
    Johnson, B.H. and Hecht, M.H. 1994. Recombinant proteins can be isolated from E. coli by repeated cycles of freezing and thawing. Bio/Technology 12:1357-1360.
    Joseph-Liauzun, E., Legoux, R., Guerveno, V., Marchese, E., and Ferra, P. 1990. Human recombinant interleukin-1 isolated from E. coli by simple osmotic shock. Gene 86:291-295.
    Kronheim, S.R., Cantrell, M.A., Deeley, M.C., March, C.J., Glackin, P.J., Anderson, D.M., Hemenway, T., Merriam, J.E., Cosman, D., and Hopp, T.P. 1986. Purification and characterization of human interleukin-1 expressed in Escherichia coli. Bio/Technology 4:1078-1082.
    Livi, G.P., Lillquist, J.S., Ferrara, A., Sathe, G.M., Simon, P.L., Meyers, C.A., Gorman, J.A., and Young, P.R. 1991. Secretion of N-glycosylated interleukin-1 in Saccharomyces cerevisiae using a leader peptide from Candida albicans. Effect of N-linked glycosylation on biological activity. J. Biol. Chem. 266:15348-15348.
    McMahan, C.J., Slack, J.L., Mosley, B., Cosman, D., Lupton, S.D., Brunton, L.L., Grubin, C.E., Wignall, J.M., Jenkins, N.A., Brannan, C.I., Copeland, N.G., Huebner, K., Croce, C.M., Cannizzarro, L.A., Benjamin, D., Dower, S.K., Spriggs, M.K., and Sims, J.E. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:2821-2832.
    Meyers, C.A., Johanson, K.O., Miles, L.M., McDevitt, P.J., Simon, P.L., Webb, R.L., Chen, M.-J., Holskin, B.P., Lillquist, J.S., and Young, P.R. 1987. Purification and characterization of human recombinant interleukin-1. J. Biol. Chem 262:11176-11181.
    Nash, H.A., Robertson, C.A., Flamm, E., Weisberg, R.A., and Miller, H. 1987. Overproduction of Escherichia coli integration host factor, a protein with nonidentical subunits. J. Bacteriol 169:4124-4127.
    Neidhardt, F.C. 1987. Chemical composition of Escherichia coli. In Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (F.C. Neidhardt, J.L. Ingraham, K.B. Low, B. Magasanik, M. Schaechter, and H.E. Umbarger, eds.) pp. 3-6. American Society for Microbiology, Washington, D.C.
    Priestle, J.P., Schar, H.-P., and Grutter, M.G. 1988. Crystal structure of the cytokine interleukin 1. EMBO J. 7:339-343.
    Saito, S. and Tsuchiya, T. 1984. Characteristics of n-octyl -d-thioglucopyranoside, a new non-ionic detergent useful for membrane biochemistry. Biochem. J. 222:829-832.
    Schreuder, H., Tardif, C., Trump-Kallmeyer, S., Soffientini, A., Sarubbi, E., Akeson, A., Bowlin, T., Yanofsky, S., and Barret, R.W. 1997. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386:194-200.
    Scopes, R.K. 1994. Protein Purification: Principles and Practice, 3rd ed. Springer-Verlag, New York and Heidelberg.
    Sherwood, R.F. 1992. Making bacterial extracts suitable for chromatography. Meth. Mol. Biol. 11:287-305.
    Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., Elliston, K.O., Ayala, J.M., Casano, F.J., Chin, J., Ding, G.J.-F., Egger, L.A., Gaffney, E.P., Limjuco, G., Palyha, O.C., Raju, S.M., Rolando, A.M., Salley, J.P., Yamin, T.-T., and Tocci, M.J. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 processing in monocytes. Nature 356:768-774.
    Vigers, G.P.A., Anderson, L.J., Caffes, P., and Brandhuber, B.J. 1997. Crystal structure of the type-1 interleukin-1 receptor complexed with interleukin-1. Nature 386:190-194.
    Wingfield, P., Payton, M., Tavernier, J., Barnes, M., Shaw, A., Rose, K., Simona, M.G., Demczuk, S., Williamson, K., and Dayer, J.M. 1986. Purification and characterization of human interleukin-1 expressed in recombinant Escherichia coli. Eur. J. Biochem. 160:491-497.
    Wingfield, P.T., Graber, P., Rose, K., Simona, M.G., and Hughes, G.J. 1987. Chromatofocusing on N-terminally processed forms of proteins. J. Chromatogr. 387:291-300.
    Wood, W.I. 1976. Tables for the preparation of ammonium sulfate solutions. Anal. Biochem 73:250-257.
    Yem, A.W., Richard, K.A., Staite, N.D., and Deibel, M.R. 1988. Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1. Lymphokine Res. 7:85-92.
    Zimmerman, S.B. and Trach, S. 1991. Estimation of macromolecular concentrations and excluded volume effects in the cytoplasm of Escherichia coli. J. Mol. Biol. 222:599-620.
 Key Reference
    Deutscher, M.P., (ed.) 1990. Guide to Protein Purification. In Methods in Enzymology, vol. 182. Academic Press, San Diego.

Good coverage of classical protein purification methods.

    Janson, J.-C. and Ryden, L., (eds.) 1998. Protein Purification: Principles, High Resolution Methods and Applications, 2nd ed. John Wiley & Sons, Hoboken, N.J.

Useful reference on protein purification.

    Scopes, R.K. 1994. See above

Emphasizes first principles.

    Simpson, R.J., (ed.) 2004. Purifying Proteins for Proteomics: A Laboratory Manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.

Well illustrated coverage of modern protein purification methods.

    Wingfield et al., 1986. See above.

The original publication on which Basic Protocol is based.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Author Notes

Paul Wingfield
August 17, 2009

In future updates we will be providing more example purifications especially from other host systems

Paul Wingfield
August 18, 2009

The purification of IL-b is still a very good example of a classical protein purification scheme and by mix and matching the ion-exchangers, can be used to purify many soluble proteins. In unit 6.1 (overview of protein purification), several more examples are described. If the proteins are tagged then the ion-exchange steps may not be required although the initial DEAE step is usually a great clean-up step removing both proteinaceous and non-proteinaceous contaminants. The final stage of purification should always be gel filtration. It gives some degree of purification based on the physical state of the protein and gives one opportunity to exchange the buffer. Sometimes the main issue with protein purification in general is maintaining solubility. The control of pH, salt concentration, state of reduction and the inclusion of additives are all usually optimized during the course of several purification attempts.  

Looking for Answers?
Do you have tips, tricks, or improvements to share?

Join the Conversation

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.